Lucid Diagnostics (NASDAQ:LUCD) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Lucid Diagnostics (LUCD) operate in?

Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

Lucid Diagnostics Stock (NASDAQ: LUCD) stock price, news, charts, stock research, profile.

Open	$0.79
Close	$0.78
Volume / Avg.	374.39K / 427.73K
Day Range	$0.78 - $0.80
52 Wk Range	0.63 - 1.58
Market Cap	$46.29M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	1.74%
Days to Cover	1

Recent News

Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

October's 4 Best Penny Stocks: High-Risk, High-Reward Picks

Most investors' definition of a penny stock has broadened to include not just companies trading at less than $1 per share, but also those with slightly higher stock prices up to about $5 per share. Regardless of your exact threshold, these firms remain a high-risk, high-reward proposition.

MarketBeat

October's 4 Best Penny Stocks: High-Risk, High-Reward Picks

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.79
Close	$0.78
Volume / Avg.	374.39K / 427.73K
Day Range	$0.78 - $0.80
52 Wk Range	0.63 - 1.58
Market Cap	$46.29M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	1.74%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Lucid Diagnostics (LUCD) stock?

You can purchase shares of Lucid Diagnostics (NASDAQ:LUCD) through any online brokerage.

View our list of the best stock brokerages

Who are Lucid Diagnostics (LUCD) competitors?

Other companies in Lucid Diagnostics’s space includes: Precision Optics Corp (NASDAQ:POCI), Nexalin Technology (NASDAQ:NXL), Modular Medical (NASDAQ:MODD), NeuroOne Medical Tech (NASDAQ:NMTC) and Femasys (NASDAQ:FEMY).

What is the forecast, or price target, for Lucid Diagnostics (LUCD) stock?

Lucid Diagnostics has a consensus price target of $3.67.

What is the current price for Lucid Diagnostics (LUCD)?

The stock price for Lucid Diagnostics (NASDAQ: LUCD) is $0.78 last updated December 20, 2024 at 7:31 PM EST.

Does Lucid Diagnostics (LUCD) pay a dividend?

There are no upcoming dividends for Lucid Diagnostics.

When is Lucid Diagnostics (NASDAQ:LUCD) reporting earnings?

Lucid Diagnostics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is Lucid Diagnostics (LUCD) going to split?

There is no upcoming split for Lucid Diagnostics.

What sector and industry does Lucid Diagnostics (LUCD) operate in?

Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

Comments

Lucid Diagnostics

Lucid Diagnostics (LUCD) Forecast